Is my 6‑year‑4‑month‑old daughter, who is 131.5 cm tall and growing about 7 cm per year, reaching roughly 73 % of her predicted adult height of 180 cm ± 8 cm, showing normal growth or does she require further evaluation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 30, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Vaša kćerka pokazuje normalan rast i ne zahtijeva dodatnu evaluaciju u ovom trenutku

Analiza rasta

Na osnovu dostupnih podataka, vaša kćerka raste normalno i ne postoje indikacije za endokrinološku evaluaciju. Njena trenutna visina od 131,5 cm u dobi od 6 godina i 4 mjeseca, uz godišnji rast od ~7 cm, odgovara normalnom rastu za njenu dob 1.

Ključni pokazatelji normalnog rasta:

Brzina rasta je normalna:

  • Godišnji rast od 7 cm je u normalnom rasponu za djecu predškolskog uzrasta (4-7 cm/godišnje) 1
  • Normalna brzina rasta isključuje endokrine uzroke niskog rasta kao što su deficit hormona rasta, hipotireoza ili Cushingov sindrom 2

Genetski potencijal je adekvatan:

  • Predviđena odrasla visina od 180 cm ± 8 cm (raspon 172-188 cm) je između 75. i 95. percentila za odrasle žene
  • Dostigla je 73% svoje odrasle visine, što je u skladu sa normalnim obrascem rasta 3

Nema indikacija za endokrinološku evaluaciju:

  • Smjernice jasno navode da se endokrinološka evaluacija ne preporučuje osim ako dijete ima smanjenu visinu u odnosu na genetski potencijal I smanjenu brzinu rasta 2
  • Vaša kćerka ima normalnu brzinu rasta, što isključuje potrebu za testiranjem

Praćenje rasta

Nastavite sa redovnim praćenjem:

  • Mjerite visinu svakih 4-6 mjeseci 1
  • Pratite da li dijete nastavlja da raste duž svoje percentilne krivulje
  • Alarm signal bi bio prelazak nekoliko percentilnih linija prema dolje između 3. godine i kasnog djetinjstva 1

Kada bi bila potrebna evaluacija:

Endokrinološka evaluacija bi bila indicirana samo ako bi se pojavili 2:

  • Usporena brzina rasta (prelazak percentilnih linija prema dolje)
  • Nastavak dobijanja na težini uz usporavanje rasta u visinu
  • Dodatni simptomi (glavobolje, vizuelni problemi, znaci hipotireoidizma)

Važna napomena o predvikciji visine

Predviđena visina od 180 cm ± 8 cm na osnovu rendgena šake (koštana dob) ima standardnu grešku od 4-5 cm 3. Ovo znači da je stvarna odrasla visina vjerovatno između 172-188 cm, što je i dalje iznad prosječne visine za žene.

Trenutno stanje vaše kćerke ne zahtijeva nikakvu intervenciju - ona raste normalno prema svom genetskom potencijalu.

References

Related Questions

What is the predicted adult stature of a son whose father is 6 ft 3 in and mother is 6 ft 0 in?
At what age should the mid‑parental (target) height be calculated for a child?
What is the expected adult height of a male child whose father is 6 ft 3 in and mother is 5 ft 8 in?
What is the predicted adult height of a male child whose father is 6 ft 6 in and mother is 5 ft 2 in?
What is the predicted adult height of a child if the father is 186cm tall and the mother is 157cm tall?
Is there an antipsychotic medication available in a gel formulation?
Should a 68-year-old woman with a 4-day new-onset crown-region headache (8/10) and intermittent lower-extremity weakness be evaluated urgently for a possible intracranial cause?
What is the appropriate treatment for varicella‑zoster virus (VZV) pneumonitis?
For a patient with significant edema who was on 20 mg of furosemide (Lasix) with minimal response and had the dose increased in the emergency department, how often and which laboratory tests should be monitored while on the higher furosemide dose?
When can fenofibrate and rosuvastatin (Crestor) 40 mg be resumed in a patient with AST 233 U/L, ALT 107 U/L, normal alkaline phosphatase, and CK decreased from 18,000 U/L to 4,900 U/L?
What are the alternatives to Vemlidy (tenofovir alafenamide) for treating chronic hepatitis B?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.